Abstract |
The antiviral activity of Panavir was studied on a model of mice infected with the strain Sofjin of tick-borne encephalitis (TBE) virus. The efficacy of Panavir was studied in the treatment of the chronic (monotherapy; 30 patients) and acute febrile and meningeal (combined therapy; n = 113) forms of TBE. Panavir was found to have a positive effect on the clinical course of TBE and the immune mechanisms of the body's protection.
|
Authors | A A Litvin, L I Ratnikova, P G Deriabin |
Journal | Voprosy virusologii
(Vopr Virusol)
2009 May-Jun
Vol. 54
Issue 3
Pg. 26-32
ISSN: 0507-4088 [Print] Russia (Federation) |
PMID | 19537094
(Publication Type: Controlled Clinical Trial, English Abstract, Journal Article)
|
Chemical References |
- Antibodies, Viral
- Antigens
- Antioxidants
- Probucol
|
Topics |
- Adult
- Aged
- Animals
- Animals, Newborn
- Antibodies, Viral
(blood)
- Antigens
(blood)
- Antioxidants
(administration & dosage, therapeutic use)
- Drug Evaluation, Preclinical
- Encephalitis, Tick-Borne
(blood, drug therapy, immunology)
- Female
- Humans
- Injections, Intravenous
- Lymphocyte Count
- Lymphocyte Subsets
(immunology)
- Male
- Mice
- Middle Aged
- Probucol
(administration & dosage, therapeutic use)
- Treatment Outcome
|